Potential Effect of Probiotics on the Modulating of Gut Microbiota in Autism Spectrum Disorders (ASD)
Journal of Pharmaceutical Research International,
Page 26-38
DOI:
10.9734/jpri/2021/v33i931222
Abstract
Microbiota is the summation of all microorganisms living in the body. The alteration in microbiota can lead to chronic diseases, however; colonization with different commensal bacteria can correct these deficits. Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by inadequate communication skills and social withdrawal and its etiology is uncertain. Typical gastrointestinal (GI) disorders symptoms are associated with ASD, in a prevalence range from 23% to 70%. The method of communication between the brain and the gut microbiota is likely the microbiota-gut-brain axis. Therefore, intervention studies have been published based on the use of prebiotics, probiotics and fecal microbiota transplantation (FMT). In this review, the possible correlation between gut microbiota and ASD is demonstrated. Additionally, how probiotics and microbial fecal microbiota transplantation (FMT) could modulate the gut microbiota and might represent a potential therapy for patients with ASD. Nearly all the GI functions postulated to be affected in ASD are improved by probiotics in animal studies. (FMT) ensures the transfer of several hundred bacterial strains, as opposed to probiotic therapy where only certain bacterial strains are supplemented. For ASD patients with dysbiosis, FMT is an interesting new therapeutic choice that could be considered.
Keywords:
- Probiotics
- gut microbiota
- dysbiosis
- autism spectrum disorders.
How to Cite
References
Published 2016 Sep 30
Buie T. Potential etiologic factors of microbiome disruption in autism. Clin Ther. 2015;37(5):976-983.
DOI: 10.1016/j.clinthera.2015.04.001
Iovene MR, Bombace F, Maresca R, et al. Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders. Mycopathologia. 2017;18(3-4): 349-363.
DOI: 10.1007/s11046-016-0068-6
De Angelis M, Piccolo M, Vannini L, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLOS One. 2013;8(10):1-18.
DOI: 10.1371/journal.pone.0076993
Hyochol AHN, et al 2017. HHS public access. Physiol Behav. 2017;176(10): 139-148.
DOI:10.1146/annurev-neuro-072116-031347
Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr. 2013; 167(4):374-379.
DOI: 10.1001/jamapediatrics.2013.497
Rodríguez JM, Murphy K, Stanton C, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Heal Dis. 2015;26(0).
DOI: 10.3402/mehd.v26.26050
Gevers D, Knight R, Petrosino JF, et al. The human microbiome project: A community resource for the healthy human microbiome. PLOS Biol. 2012;10(8):6-10.
DOI: 10.1371/journal.pbio.1001377
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLOS Biol. 2016;14(8):e1002533.
DOI: 10.1371/journal.pbio.1002533
PMID: 27541692
PMCID: PMC4991899
Hill DA, Hoffmann C, ABT Mc, et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010;3(2):148-58.
DOI: 10.1038/mi.2009.132
EPUB 2009 nov 25
PMID: 19940845
PMCID: PMC2824244
Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol; 2009.
DOI: 10.1038/nrmicro2245
Oh D, Cheon KA. Alteration of gut microbiota in autism spectrum disorder: an overview. SOA Chongsonyon Chongsin UIHAK. 2020;31(3):131-145.
DOI: 10.5765/jkacap.190039
Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1-4.
DOI: 10.1136/gut.53.1.1
Chung H, Pamp SJ, Hill JA, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell. 2012;149(7):1578-93.
DOI: 10.1016/j.cell.2012.04.037
PMID: 22726443
PMCID: pmc3442780
El Aidy S, Hooiveld G, Tremaroli V, Bäckhed F, Kleerebezem M. The gut microbiota and mucosal homeostasis: colonized at birth or at adulthood, does it matter? Gut Microbes. 2013;4(2):118-124.
DOI: 10.4161/gmic.23362
Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539-44.
DOI: 10.1126/science.aad9378.
PMID: 27126036; PMCID: pmc5050524
Ediriweera DS, Kasturiratne A, Pathmeswaran A, et al. Mapping the risk of snakebite in sri lanka - A national survey with geospatial analysis. PLOS Negl Trop Dis. 2016;10(7):e0004813.
DOI: 10.1371/journal.pntd.0004813
Pmid: 27391023
PMCID: pmc4938527
Zapka C, Leff J, Henley J, et al. Comparison of standard culture-based method to culture-independent method for evaluation of hygiene effects on the hand microbiome. Mbio. 2017;8(2): e00093-17.
Published 2017 mar 28
DOI: 10.1128/mbio.00093-17
Fakhoury M. Autistic spectrum disorders: a review of clinical features, theories and diagnosis. Int J Dev Neurosci. 2015;43: 70-77.
DOI: 10.1016/j.ijdevneu.2015.04.003
Devlin B, Boone BE, Levy SE, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485(7397):242-246.
DOI: 10.1038/nature11011
Newschaffer CJ, Croen LA, Daniels J, et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007;28:235-58.
DOI:10.1146/annurev.publhealth.28.021406.144007
PMID: 17367287
Rossignol DA, Frye RE. Expert review a review of research trends in physiological abnormalities in autism spectrum disorders : immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012:389-401.
DOI: 10.1038/mp.2011.165
Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, united states, 2014. MMWR Surveill Summ. 2018;27;67(6):1-23.
Doi: 10.15585/mmwr.ss6706a1
Mezzelani A, Raggi ME, Marabotti A, Milanesi L. Ochratoxin a as possible factor trigging autism and its male prevalence via epigenetic mechanism. Nutr Neurosci. 2016;19(1):43-6.
DOI:10.1179/1476830515z.000000000186
EPUB 2015 Jan 17
PMID: 25597866
Kushak RI, Winter Hs. Research in autism spectrum disorders intestinal microbiota, metabolome and gender dimorphism in autism spectrum disorders. Res Autism Spectr Disord. 2018;49:65-74.
DOI: 10.1016/j.rasd.2018.01.009
Vahia VN. Diagnostic and statistical manual of mental disorders 5: A quick glance. Indian J Psychiatry. 2013;55(3): 220-223.
DOI: 10.4103/0019-5545.117131
Berding K, donovan sm. Microbiome and nutrition in autism spectrum disorder: Current knowledge and research needs. Nutr Rev. 2016;74(12):723-736.
DOI: 10.1093/nutrit/nuw048
PMID: 27864534
Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008; 9(5):341-55.
DOI: 10.1038/nrg2346
Raz R, Roberts AL, Lyall K, Hart JE, Just AC, Laden F, et al. Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case-control analysis within the nurses' health study ii cohort. Environ Health Perspect. 2015;123(3):264-70.
DOI: 10.1289/ehp.1408133
EPUB 2014 dec 18
PMID: 25522338
PMCID: pmc4348742
Shelton JF, Geraghty EM, Tancredi DJ, Delwiche LD, Schmidt RJ, Ritz B, Hansen RL, Hertz-Picciotto I. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the charge study. Environ Health Perspect. 2014;122(10): 1103-9.
DOI: 10.1289/ehp.1307044
Epub 2014 jan 23
Bolte ER. Autism and Clostridium tetani. Med hypotheses. 1998;51(2):133-44.
DOI: 10.1016/s0306-9877(98)90107-4
PMID: 9881820
Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68(11):1095-102.
DOI: 10.1001/archgenpsychiatry.2011.76
EPUB 2011 Jul 4
PMID: 21727249
PMCID: PMC4440679
Sandin S, Lichtenstein P, Kuja-Halkola R, et al. The familial risk of autism. JAMA. 2014;311(17):1770-7.
DOI: 10.1001/jama.2014.4144
PMID: 24794370; PMCID: PMC4381277
Holingue C, Newill C, Lee LC, et al. Gastrointestinal symptoms in autism spectrum disorder: a review of the literature on ascertainment and prevalence. Autism Res. 2018;11(1):24-36.
DOI: 10.1002/aur.1854
Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 2014; 44(5):1117-1127.
DOI: 10.1007/s10803-013-1973-x
Myers SM, Johnson CP. American academy of pediatrics council on children with disabilities. Management of children with autism spectrum disorders. Pediatrics. 2007;120(5):1162-82.
DOI: 10.1542/Peds.2007-2362
Epub 2007 Oct 29
PMID: 17967921
Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays. 2014; 36(10):933-9.
DOI: 10.1002/bies.201400075
EPUB 2014 Aug 22
PMID: 25145752
Gorrindo P, Williams KC, Lee EB, Walker LS, Mcgrew SG, Levitt P. Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res. 2012;5(2):101-8.
DOI: 10.1002/aur.237
PMID: 22511450
PMCID: PMC3335766
De Angelis M, Francavilla R, Piccolo M, De Giacomo A, Gobbetti M. Autism spectrum disorders and intestinal microbiota. Gut microbes. 2015;6(3):207-13.
DOI: 10.1080/19490976.2015.1035855
PMID: 25835343
PMCID: PMC4616908
Mead J, Ashwood P. Evidence supporting an altered immune response in asd. Immunol lett. 2015;163(1):49-55.
DOI: 10.1016/j.imlet.2014.11.006
Garcia-Gutierrez E, Narbad A, Rodríguez JM. Autism spectrum disorder associated with gut microbiota at immune, metabolomic, and neuroactive level. Front Neurosci. 2020;14:578666.
Published 2020 Oct 8
DOI: 10.3389/fnins.2020.578666
Srikantha P, Hasan Mohajeri M. The possible role of the microbiota-gut-brain-axis in autism spectrum disorder. Int J Mol Sci. 2019;20(9):14-19.
DOI: 10.3390/ijms20092115
Wang Y, Kasper LH. Brain, behavior, and immunity the role of microbiome in central nervous system disorders. Brain Behav Immun. 2014;38:1-12.
DOI: 10.1016/j.bbi.2013.12.015
Buie T, Campbell DB, Fuchs GJ 3rd, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with asds: a consensus report. Pediatrics. 2010;125(1):s1-18.
DOI: 10.1542/peds.2009-1878c
PMID: 20048083
Nikolov RN, Bearss KE, Lettinga J, et al. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord. 2009; 39(3):405-13.
DOI: 10.1007/s10803-008-0637-8
Epub 2008 Sep 13
PMID: 18791817
De Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418-24.
DOI:10.1097/mpg.0b013e3181dcc4a5. PMID: 20683204
Redinbo MR. The microbiota, chemical symbiosis, and human disease nasal – sinus. J Mol Biol. 2014;426(23):3877-3891.
DOI: 10.1016/j.jmb.2014.09.011
Viggiano D, Ianiro G, Vanella G, Bibbò S, Bruno G, Simeone G, Mele G. Gut barrier in health and disease: focus on childhood. Eur Rev Med Pharmacol Sci. 2015; 19(6):1077-85.
PMID: 25855935
Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13(9): 517-528.
DOI: 10.1038/nrgastro.2016.107
Zeidán-Chuliá F, Fonseca Moreira JC. Clostridium bacteria and its impact in autism research: thinking “outside the box” of neuroscience. Commun Disord Deaf Stud Hearing Aids. 2013;1:101.
DOI: 10.4172/2375-4427.1000101
Kohane IS, McMurry A, Weber G, Macfadden D, Rappaport L, Kunkel L, Bickel J, Wattanasin N, Spence S, Murphy S, Churchill S. The co-morbidity burden of children and young adults with autism spectrum disorders. PLOS One. 2012; 7(4):e33224.
DOI: 10.1371/journal.pone.0033224
Epub 2012 apr 12
PMID: 22511918
PMCID: PMC3325235
Li Q, Han Y, Dy ABC, Hagerman RJ. The Gut Microbiota and Autism Spectrum Disorders. Front Cell Neurosci. 2017;11:120.
DOI: 10.3389/fncel.2017.00120
PMID: 28503135
PMCID: PMC5408485
Van De Sande MMH, Van Buul VJ, Brouns FJPH. Autism and nutrition: the role of the gut-brain axis. Nutr Res Rev. 2014;27(2): 199-214.
DOI: 10.1017/s0954422414000110
Fiorentino M, Sapone A, Senger S, et al. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7(1):1-17.
DOI: 10.1186/s13229-016-0110-z
Santocchi E, Guiducci L, Fulceri F, et al. Gut to brain interaction in autism spectrum disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters. BMC Psychiatry. 2016;16(1): 1-16.
DOI: 10.1186/s12888-016-0887-5
Emanuele E, Orsi P, Boso M, et al. Low-grade endotoxemia in patients with severe autism. Neurosci Lett. 2010;471(3): 162-165.
DOI: 10.1016/j.neulet.2010.01.033
Fond G, Boukouaci W, Chevalier G, et al. The psychomicrobiotic: Targeting microbiota in major psychiatric disorders: a systematic review le microbiote intestinal : un rôle potentiel dans les troubles psychiatriques majeurs. Pathol Biol. 2015; 63:35-42.
Available:http://dx.doi.org/10.1016/j.patbio.2014.10.003
Hsiao EY, Mcbride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013; 155(7):1451-1463.
DOI: 10.1016/j.cell.2013.11.024
Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012; 42(1):71-78.
DOI: 10.1007/s12016-011-8291-x
Sherwin E, Sandhu KV, Dinan TG, Cryan JF. May the force be with you : the light and dark sides of the microbiota – gut – brain axis in neuropsychiatry. CNS Drugs. 2016;30(11):1019-1041.
DOI: 10.1007/s40263-016-0370-3
Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol. 2015;52(12):7577-7587.
DOI: 10.1007/s13197-015-1921-1
Tomova A, Husarova V, Lakatosova S, et al. Physiology & behavior gastrointestinal microbiota in children with autism in slovakia. Physiol Behav. 2015;138: 179-187.
DOI: 10.1016/j.physbeh.2014.10.033
Navarro F, Liu Y, Rhoads JM. Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol. 2016;22(46):10093-10102.
DOI: 10.3748/wjg.v22.i46.10093
Dinan TG, Cryan JF. Gut instincts: Microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. 2017; 595(2):489-503.
DOI: 10.1113/jp273106
Epub 2016 Dec 4
PMID: 27641441
PMCID: pmc5233671
Martínez-Pedraza FDE l, Carter AS. Autism spectrum disorders in young children. Child Adolesc Psychiatr Clin N Am. 2009;18(3):645-663.
DOI: 10.1016/j.chc.2009.02.002
Abdellatif B, McVeigh C, Bendriss G, Chaari A. The promising role of probiotics in managing the altered gut in autism spectrum disorders. International Journal of Molecular Sciences. 2020;21(11):4159.
Available:https://doi.org/10.3390/ijms21114159
Ho LKH, Tong VJW, Syn N, Nagarajan N, Tham EH, Tay SK, et al. Gut microbiota changes in children with autism spectrum disorder: a systematic review. Gut Pathog. 2020;12:6.
DOI: 10.1186/s13099-020-0346-1
PMID: 32025243
PMCID: PMC6996179
Bezawada N, Phang TH, Hold GL, Hansen R. Autism spectrum disorder and the gut microbiota in children: a systematic review. Ann Nutr Metab. 2020;76(1):16-29.
DOI: 10.1159/000505363
EPUB 2020 Jan 24
PMID: 31982866
Shaaban SY, El Gendy YG, Mehanna NS, El-Senousy WM, El-Feki HSA, Saad K, et al. The role of probiotics in children with autism spectrum disorder: a prospective, open-label study. Nutr Neurosci. 2018; 21(9):676-681.
DOI: 10.1080/1028415x.2017.1347746
Epub 2017 Jul 7
PMID: 28686541
Umbrello G, Esposito S. Microbiota and neurologic diseases : Potential effects of probiotics. J Transl Med. 2016:1-11.
DOI: 10.1186/s12967-016-1058-7
Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2009;297(5): 940-949.
DOI: 10.1152/ajpgi.00141.2009
Buffington SA, Viana G, Prisco D, et al. Microbial reconstitution reverses maternal diet- induced social and synaptic deficits in offspring article microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell. 2016; 165(7):1762-1775.
DOI: 10.1016/j.cell.2016.06.001
Getz KD, Anderka MT, Werler MM, Jick SS. Maternal pre-pregnancy body mass index and autism spectrum disorder among offspring: a population-based case-control study. Paediatr perinat epidemiol. 2016;30(5):479-87.
DOI: 10.1111/ppe.12306
Epub 2016 May 30
PMID: 27239935
PMCID: PMC5849232
Li M, Fallin MD, Riley A, Landa R, Walker SO. The association of maternal obesity and diabetes with autism and other developmental disabilities. Pediatrics. 2016;137(2):e20152206.
DOI: 10.1542/peds.2015-2206
Nahum K, Bmedsc S, Friger M, et al. Smfm papers prenatal exposure to gestational diabetes mellitus as an. Am J Obstet Gynecol. 2016;215(3): 380.e1-380.e7.
DOI: 10.1016/j.ajog.2016.03.030
Ka J. The level of arabinitol in autistic children after probiotic therapy. Nutrition. 2012;28:124-126.
DOI: 10.1016/j.nut.2011.08.002
Parracho HMRT, Gibson GR, Knott F, Bosscher D, Kleerebezem M, McCartney AL. A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. International Journal of Probiotics and Prebiotics. 2010;5(2): 69-74.
Grossi E, Melli S, Dunca D, Terruzzi V. Unexpected improvement in core autism spectrum disorder symptoms after long-term treatment with probiotics. Sage Open Medical Case Reports; 2016.
DOI: 10.1177/2050313x16666231
Kang DW, Adams JB, Gregory AC, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5(1):1-16.
DOI: 10.1186/s40168-016-0225-7
Panchal P, Budree S, Scheeler A, et al. Scaling safe access to fecal microbiota transplantation: past, present, and future. Curr Gastroenterol Rep. 2018;20(4):14.
Doi: 10.1007/s11894-018-0619-8
Mohajeri MH. The role of the microbiome for human health : from basic science to clinical applications. Eur J Nutr. 2018; 57(1):1-14.
DOI: 10.1007/s00394-018-1703-4
Ianiro G, Bibbò S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets. 2014;15(8):762-70.
DOI:10.2174/1389450115666140606111402
PMID: 24909808
Skosnik PD, Cortes-Briones JA. Targeting the ecology within : The role of the gut – brain axis and human microbiota in drug addiction. Med Hypotheses. 2016;93: 77-80.
DOI: 10.1016/j.mehy.2016.05.021
Okumura T, Kudo S, Hayashi T, et al. Surveillance after endoscopic submucosal fecal microbiota transplantation for institute of digestive diseases, Chinese PLA general hospital, Beijing, department of internal medicine, university of Minnesota, department of gastroenterology, Fujita He. Gastrointest Endosc. 2019;89(6): ab512-ab513.
DOI: 10.1016/j.gie.2019.03.857
Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29(1): 79-84.
DOI: 10.1097/mog.0b013e32835a4b3e
PMID: 23041678
Rossen NG, MacDonald JK, Vries EM De, et al. Fecal microbiota transplantation as novel therapy in gastroenterology : a systematic review. World J Gastroenterol. 2015;21(17):5359-5371.
DOI: 10.3748/wjg.v21.i17.5359
Goo N, Bae HJ, Park K, et al. The effect of fecal microbiota transplantation on autistic-like behaviors in FMR1 KO mice. Life Sci. 2020;262:118497.
DOI: 10.1016/j.lfs.2020.118497
Kelly CR, Kahn S, Kashyap P, et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149(1):223-237.
DOI: 10.1053/j.gastro.2015.05.008
Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes. 2013;4(1):53-65.
DOI: 10.3920/bm2012.0039
PMID: 23257018
Fattorusso A, Di Genova L, Dell’isola GB, Mencaroni E, esposito S. Autism spectrum disorders and the gut microbiota. Nutrients. 2019;11(3).
DOI: 10.3390/NU11030521
-
Abstract View: 361 times
PDF Download: 130 times